Brief: China Biotech Services Posts FY Revenue Of HK$212 Mln
28/03/2024 13:32
March 28 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* FY REVENUE HK$212 MILLION VERSUS HK$1.85 BILLION
* FY LOSS ATTRIBUTABLE HK$95.4 MILLION VERSUS PROFIT
HK$258.1
MILLION
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)